We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision

By LabMedica International staff writers
Posted on 22 Mar 2023

Near Patient Testing (NPT), also known as Point of Care Testing (POCT), is a rapidly growing area within the field of In vitro diagnostics (IVDs). More...

NPT is now recognized for its key role in making services more patient-centered by bringing diagnostic testing closer to the patient. This shift has the potential to significantly transform the way healthcare services are delivered to patients. By enabling timely diagnosis at the bedside, in community settings, or even in general practice, the delivery of care can be made much more efficient, allowing patients to receive the right diagnosis and treatment in a timely and convenient manner. Now, a handheld portable immunoanalyzer with the sensitivity and precision of centralized laboratory equipment is currently being developed in a form factor suitable for low-cost, point-of-care testing anywhere in the world.

Proxim Diagnostics Corp. (Santa Clara, CA, USA) is developing the Profile System, a portable and fully automated immunodiagnostic device that can run several types of multiplexed assays using disposable cartridges. The system performs critical laboratory tests near the patient using whole blood without sacrificing sensitivity and precision to deliver the most critical information to the doctors right when they need it. The Profile System is battery operated, and offers a touch-screen display interface, along with wireless, Ethernet, and USB connectivity.

The handheld device is expected to enhance the ability of clinicians to perform rapid, high-quality testing at the point of care, such as in emergency rooms, intensive care units, nursing homes, community/remote clinics and in-home care, as well as in disaster relief and defense situations. The system is currently available for research use only. Proxim is also developing several immunoassays for sepsis, cardiology, and infectious diseases that can match the sensitivity and precision of tests that are run on larger, centralized laboratory equipment.

Related Links:
Proxim Diagnostics Corp.


Gold Member
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.